SENTAN Pharma Reports Basic Research Results on the Brown Rice-Derived Ingredient γ-Oryzanol
Pharmaceutical venture SENTAN Pharma has reported positive results in its basic research on γ-oryzanol, an ingredient derived from brown rice. This demonstrates the effectiveness of the company's proprietary particle technology and holds promise for future product development.
📋 Article Processing Timeline
- 📰 Published: April 22, 2026 at 13:00
- 🔍 Collected: April 22, 2026 at 13:31 (31 min after Published)
- 🤖 AI Analyzed: April 22, 2026 at 19:58 (6h 26m after Collected)
SENTAN Pharma is a venture company that provides technology to enhance the effectiveness of products by applying its proprietary nano-particle and micro-particle technologies to the manufacturing processes of pharmaceuticals and health foods.